Next Article in Journal
Monaural Sound Localization Based on Structure-Induced Acoustic Resonance
Next Article in Special Issue
Nano-Magnetic Immunosensor Based on Staphylococcus Protein A and the Amplification Effect of HRP-Conjugated Phage Antibody
Previous Article in Journal
Passive Localization of Mixed Far-Field and Near-Field Sources without Estimating the Number of Sources
Previous Article in Special Issue
A Fumonisins Immunosensor Based on Polyanilino-Carbon Nanotubes Doped with Palladium Telluride Quantum Dots
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Application on Gold Nanoparticles-Dotted 4-Nitrophenylazo Graphene in a Label-Free Impedimetric Deoxynivalenol Immunosensor

Sensor Laboratory, Chemistry Department, University of the Western Cape, Private Bag X 17, Bellville 7535, South Africa
*
Author to whom correspondence should be addressed.
Sensors 2015, 15(2), 3854-3871; https://doi.org/10.3390/s150203854
Submission received: 22 October 2014 / Revised: 17 November 2014 / Accepted: 7 December 2014 / Published: 6 February 2015
(This article belongs to the Special Issue Immunosensors 2014)

Abstract

: In this paper, we report a new concept to construct a label-free electrochemical inhibition-based immunosensor for the detection of the mycotoxin deoxynivalenol (DON) in cereal samples. The electrochemical impedance spectroscopy of tris(bipyridine) ruthenium (II) chloride was used as a marker enhanced with gold nanoparticles-dotted 4-nitrophenylazo functionalized graphene (AuNp/G/PhNO2) nanocatalyst mediated in Nafion on a glassy carbon electrode. Under the optimized conditions, the formation of immunocomplexes inhibited electron flow and increased the charge transfer resistance of the sensing interface linearly. The change in impedance was proportional to DON concentrations in the range of 6–30 ng/mL with a sensitivity and detection limit of 32.14 ΩL/ng and 0.3 μg/mL, respectively, which compares favorably with the ELISA result. The proposed sensor had a stability of 80.3%, good precision and selectivity in DON standard solution containing different interfering agents, indicating promising application prospect for this strategy in designing impedimetric, electrochemiluminescent, voltammetric or amperometric sensors.

1. Introduction

The mycotoxin deoxynivalenol (DON) is a low molecular weight metabolite and chemical by-product of the fungal species Fusarium graminearum and Fusarium culmorum which occur naturally in the soil of crop fields and contaminate a wide range of crop plants before and after harvest [1]. It belongs to a class of mycotoxins called the trichothecenes which are commonly found in cereals or cereal-based food and feedstuffs. They are classified into group A and group B compounds, depending on their structure. The most important types of group A-trichothecene are T-2 toxin and HT-2 toxin. DON falls within the group B-trichothecenes [2]. DON often co-exists with other mycotoxins such as zearalenone and nivalenol. Its levels range from μg/kg to tens of mg/kg and vary year-to-year depending on the climate, season, geographic conditions and agronomic practice. The deoxynivalenol structure (Figure 1, [1]) is characterized as a tetracyclic sesquiterpene with seven stereocentres, and six oxygen atoms which would allow for multiple hydrogen bonding, including an epoxide, a carbonyl, cyclic ether and three alcoholic OH groups [3,4].

Deoxynivalenol is toxic, but it has not been reported as having carcinogenic, teratogenic or mutagenic properties [57]. The most important structural features responsible for the biological activities of DON are the 12,13-epoxy ring, the presence of hydroxyl/acetyl groups and their position in the chemical structure of DON. Other mycotoxins like T-2 toxin, HT-2 toxin and nivalenol (NIV) also have the same effect, but it appears that they differ in their toxic capacities and it is not clear whether they work via identical mechanisms at a cellular level [4]. The acute effects of DON in animals and humans include reduced feed uptake, nausea, vomiting, diarrhoea, abdominal pain, headache, dizziness, fever, skin irritation and immunosuppression. No human deaths have been attributed to DON yet. Humans are directly exposed to these risks through foods of plant origin (cereal grains) or indirectly through foods of animal origin (kidney, liver, milk, eggs) [57].

DON is an important toxin of cereal foods and constitutes an increasing problem in several countries because the occurrence of the fungal species that produce it is very high in Nature. The growth of these fungi is season dependant and complete prevention is impossible. Because of concerns with the increasing toxic effects of DON on livestock and humans, the United States Department of Agriculture (USDA), Food & Drug Administration (FDA) and European Community have instituted advisory levels of 1 ppm for wheat products for human consumption, 5 ppm of grain products for most animal feeds and 10 ppm of grain products for cattle feed [5,6]. The European Union (EU) has also established ranges from 200 to 1750 μg/kg depending on the kind of cereal and cereal products. A provisional maximum tolerated daily intake (PMTDI) of DON for 1 μg/kg body weight (BW) was established by the World Health Organization Joint Expert Committee on Food Additives (WHOJECFA) on the basis of NOAEL (NOAEL = no observed adverse effect level) [8,9].

The analytical methods reported for the determination of DON include PCR, GC, GC-MS, HPLC, thin-layer chromatography and enzyme-linked immunosorbent assay (ELISA) [1016]. Some of these methods allow good accuracy of quantification and good detection limits, but they are not cost effective; some suffer from low selectivity and usually require significant amounts of time associated with labour-intensive sample cleanup, sophisticated instrumentation, skilled operators or technical expertise. In view of these analytical challenges, a gold nanoparticles-dotted 4-nitrophenylazo functionalised graphene (AuNp/G/PhNO2) composite was used to develop a sensor platform by applying Nafion 117 as a binder and incorporating [Ru(bpy)3]2+ as a cationic reactant on a glassy carbon electrode (GCE) [17]. The diazonium-modified platform was adopted in the construction of easy to use, rapid, cost effective and signal enhanced immunosensor for the detection and determination of DON levels in cereal food items via an impedimetric system. The formation of immunocomplexes between DON antibody and DON antigenic species to which it selectively binds inhibited the electron flow and increased the charge transfer resistance of the sensing interface linearly, with the change in impedance being proportional to DON concentration.

2. Experimental Section

2.1. Chemicals and Reagents

Deoxynivalenol antigen, DONag (formula weight, 296.32 g/mol) was purchased from Sigma-Aldrich (St. Louis, MO, USA; product code 01567-5MG), IgG1 monoclonal antibody of deoxynivalenol (DONab, 1 mg) was purchased from Antibodies-online (Aachen, Germany, order number ABIN1022125), ELISA kit (Veratox 5/5 for deoxynivalenol: 0.1 ppm) was purchased from Neogen Corporation (Lansing, MI, USA), certified corn, wheat and roasted coffee reference materials were purchased from RIDASCREEN® (Washington, MO, USA). Methanol (CH4O, HPLC grade), tris-ruthenium 2,2-bipyridine chloride (Ru(bpy)3Cl2), ethanol (C2H6O, analytical grade), bovine serum albumin (BSA), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-hydroxy-succinimide (NHS), basic salts including sodium phosphate dibasic (Na2HPO4), sodium phosphate monobasic (NaH2PO4), potassium Chloride (KCl) used in the preparation of 0.1 M phosphate-buffered saline (PBS pH 7.2), were all purchased from Sigma-Aldrich (Johannesburg, South Africa). Nafion 117 solution purchased from Fluka (Johannesburg, South Africa). Gold nanoparticles-dotted 4-nitrophenylazo functionalised graphene (AuNp/G/PhNO2) and 4-nitrophenylazofunctionalised graphene (G/PhNO2) were synthesised as described elsewhere [17]. All other chemicals were of analytical grade, Milli-Q de-ionized water (resistance over 18.2 MΩ cm) purified by a Milli-QTM system was used for aqueous solution preparations throughout. Analytical grade argon from Afrox (Cape Town, South Africa) was used to degas the system.

2.2. Apparatus

All cyclic voltammetry and chronoamperometry experiments were recorded with BASi 100B electrochemical work station (LG Fayette, TX, USA). The electrochemical impedance spectroscopy measurements were carried out using Voltalab PGL 402 from Radiometer Analytical (Lyon, France) and the data plotted in the form of complex plane diagrams (Nyquist plots). The conventional three-electrode system was adopted where the working electrode used was glassy carbon electrode (surface area = 0.071 cm2), the counter electrode was platinum wire (diameter 1.0 mm) and all potentials mentioned in all the experimental results were referred to standard silver/silver chloride (saturated KCl solution) electrode (Bioanalytical Systems Ltd., Warwickshire, UK). The electrolytes used were measured into 20 mL electrochemical cell and de-aerated with argon gas for at least 10 min before measurements. An argon atmosphere headspace was maintained throughout the duration of all the experiments.

2.3. Pre-Cleaning of Working Electrode

Prior to electrochemical modifications, glassy carbon electrode (GCE) was polished consecutively with aqueous slurries of 1.0, 0.3 and 0.05 micro alumina powder, for 1 min on a micro-cloth pad (Buehler, Düsseldorf, Germany) and rinsed thoroughly with doubly distilled water between each polishing step. Residual polishing material was removed by washing successively with 1:1 water to nitric acid solution, ethanol and doubly distilled water in an ultrasonic bath, air dried and used immediately.

2.4. Preparation of Standard Solutions

DONag was dissolved in 1 mL of analytical grade methanol to give 5 mg/mL (0.0169 M) stock solution and stored as 250 μL aliquots each in tightly sealed vials at −20 °C. Before every experiment, 1 × 10−3 M and 1 × 10−6 M of DONag standard solutions were prepared in a (3:1) mixture of methanol/PBS solution, hereafter referred to as methanolic phosphate buffer saline (MPBS) solution, and used for further dilutions. The DONab (1 mg) was reconstituted by adding 1 mL deionised water to give 1 mg/mL stock solution and stored as 250 μL aliquots each in tightly sealed vials at −20 °C.

2.5. Sample Preparation and Extraction

Following the extraction procedure described by Veratox Elisa Kit manual, 10 g of ground certified corn, wheat and roasted coffee reference materials were each weighed out into separate 250 mL capped pre-cleaned flask, mixed with 100 mL of deionised water and shaken vigorously using hand for 3 min. The mixture was allowed to settle for 2 min and then filtered using a Whatman #1 filter paper. The filtrate was collected for analysis without further preparation.

2.6. Preparation of G/PhNO2 and AuNp/G/PhNO2

G/PhNO2 and AuNp/G/PhNO2 were chemically synthesized as described previously [17]. Briefly, Graphene oxide (GO) was reduced in three stages: pre-reduction of GO, functionalisation of pr-reduced GO and post-reduction to give G/PhNO2. This was functionalized further with gold nanoparticles to give AuNp/G/PhNO2 (Figure 2 [17]).

2.7. Preparation of Sensor Platform

The sensor platform was prepared in stages as illustrated in Figure 3. (A) Nafion stock solution was diluted with 1:1 water to methanol mixture to yield 1% (v/v) solution and then AuNp/G/PhNO2 was dispersed in the 1% (v/v) Nafion solution by ultra-sonication for 30 min to form 1 mg·mL−1 uniform nano-composite. 4 μL of it was drop-casted on the surface of a pre-cleaned GCE and excess solvent was allowed to evaporate to dryness in the open at room temperature to form a thin film; (B) The Nafion/AuNp/G/PhNO2 modified GC electrode was placed in 1 mM Ru(bpy)3Cl2 aqueous solution for 2 h to incorporate [Ru(bpy)3]2+ via electrostatic and ion-exchange interactions, forming a thin film modified glassy carbon electrode depicted as GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNO2.

2.8. Immobilization of Deoxynivalenol Antibody

Before immobilization of antibody, (C) the modified electrode was first reduced electrochemically to generate an aminophenyl surface in 0.1 KCl solutions by two cyclic voltammetric scans over potential range 0 to −1200 mV at 50 mV/s [1820]; (D) the electrode was then rinsed out from the sides after reduction using deionised water and the amine on the electrode surface was activated by incubation for 60 min with 1:1 mixture of 0.5 mM EDC and 8 mM NHS.

After rinsing the electrode from the side with 0.1 M PBS (pH 7.2) solution, 30 μL of 0.2 μg/μL (in 0.1 M PBS, pH 7.2) monoclonal deoxynivalenol antibody (DONab) was spread on the electrode surface and incubated for 30 min at room temperature; (E) the electrode was again rinsed from the side using 0.1 M PBS (pH 7.2) solution to remove any physically bound antibody and then 10 μL of BSA was spread on the electrode surface to block nonspecific binding sites for 30 min at room temperature and rinsed with PBS (pH 7.2) before making impedimetric measurements; (F) the immunosensor which is depicted as GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 /DONab/BSA was incubated for 30 min in aliquots of a pH 7.2 MPBS solution containing various concentrations of DONag and measured impedimetrically [2022]. All experiments were carried out at room temperature (see Figure 3).

3. Results and Discussion

3.1. Electro-Reduction of Nitrophenyl Group to Aminophenyl Group

The modified electrode was first reduced electrochemically to obtain a modified film of 4-aminophenyl on the electrode surface in 0.1 KCl solutions by two cyclic voltammetric scans over potential range 0 to −1200 mV at scan rate of 50 mV/s. The modified electrode showed irreversible voltammogram with a reduction peak attributable to 4-nitrophenyl (-PhNO2) to 4-aminophenyl (-PhNH2) reduction at −920 mV (Ag/AgCl), see Figure 4. During the second scan, the peak observed at −920 mV in the first scan disappeared, indicating that nearly all the electroactive -PhNO2 were reduced in the first scan. However, the reduction of -PhNO2 to -PhNH2 is incomplete as evidenced by the reversible couple that appeared at E½ = −250 mV (Ag/AgCl). This couple is assigned to the aminophenyl/nitrosophenyl inter-conversion [23,24].

3.2. CV Behaviour of Electrochemically Reduced Modified Electrodes

Once the p-aminophenyl surface layer was formed, the electrochemical behaviour of the modified GC/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 electrode surface was investigated by cyclic voltammetry in the presence of [Ru(NH3)6]2+/3+ redox couple. Figure 5 shows the cyclic voltammogram for bare GC electrode, GC/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNO2 electrode and for GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 electrode, in the presence of the [Ru(NH3)6]2+/3+ redox couple. The data clearly show that the characteristic oxidation/reduction waves of the [Ru(NH3)6]2+/3+ redox couple was completely suppressed at the GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 electrode in curve (iii). This is expected for completely blocked 4-aminophenyl surface [19,21]. The suppression of the redox peaks at CV curve (iii) is attributed to repulsion forces between the positively charged redox probe and the positively charged (after reduction) amine (-PhNH2+) groups.

3.3. CV Behaviour of Stepwise Modification Processes of the Immunosensor

The electrochemical behaviour of various stages in the modification of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab immunosensor was studied by cyclic voltammetry (See Figure 6). It was observed that the immobilization of deoxynivalenol antibody (DONab) on GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 (see curve i) lead to a decrease in peak current of the [Ru(bpy)3]2+ redox probe in GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab (see curve ii). This is due to decreased electron transfer capability of the DONab modified electrode.

This result confirms that the immobilized DONab formed an insulating layer on the electrode and perturbs the interfacial electron transfer considerably. After BSA was immobilized to block the remaining active cites in order to avoid any nonspecific adsorption, a further decrease of the peak currents was observed with the fact that BSA insulates the conductive support and hinders the transmission of electrons toward the electrode surface further (curve iii). These results indicated that the immunosensor was successfully modified as premeditation. The peak current reduced further after the immunosensor was applied in detecting DON from the standard solution (curve iv).

3.4. Chronoamperometric Behaviour of Stepwise Modification Processes of the Immunosensor

The electrochemical behaviour of the stepwise modification processes of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab immunosensor was further investigated by chronoamperometry. The experiments were done in a two-step potential mode, with 2 s quiet time, and pulse width of 500 ms in a quiescent condition. The choice of potential steps was made from the cyclic voltammogram at 50 mV/s of the sensor platform in 0.1 M PBS (pH 7.2).

The Faradaic chronoamperometric measurements were in good agreement with the CV measurements. It could be observed from the chronoamperogram and bar chart in Figure 7 respectively that the current reduced with each modification step. Following the observed blocking effect of the -PhNH2 film in the previous sections, this indicates that a further blocking effect was observed after the covalent immobilization of the antibody and blocking of nonspecific binding sites with BSA.

3.5. Optimisation of Assay Condition

3.5.1. Effect of Antibody Concentration

The electrochemical responses of the immunosensor to various concentrations of DONab applied in the immobilisation step were determined by impedance spectroscopy. Different dilutions of DONab were prepared (1:10; 1:50; 1:100, 1:200 and 1:400 v/v, corresponding to 0.01, 0.02, 0.1, 0.2 and 0.4 μg/μL). 30 μL of each concentration was drop coated onto the modified electrode to obtain GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab, and then impedimetric measurements were performed in presence of 30 ng/mL DONag MPBS solution (pH 7.2). The highest Rct was obtained with 0.2 μg/μL (Figure 8), indicating the optimal formation of immune-complexes and inhibition. Thus, concentration of 0.2 μg/μL was selected for all experiments.

3.5.2. Effect of pH

In order to evaluate the influence of the pH on the immunosensor performance, it was tested by cyclic voltammetric technique in a series of PBS working solutions with pH ranging from 4.5 to 7.5. Figure 9 shows the pH effect of the detection solution on the immunosensor. The current responses in presence of 30 ng/mL DONag were monitored. There was no significant change in the peak currents between pH 4.0–6.5 indicating that the bioactivity of antigen and antibody was poor or absent in the acidic solution. Conversely, a drastic drop in peak current was observed at pH 7.0 and the lowest current was at pH 7.2. This could be attributed to the formation of immunocomplexes by the binding of DONab and DONag which led to inhibition of electron flow. Therefore PBS of pH 7.2 was adopted as the incubation solution considering the response of the immunosensor.

3.5.3. Effect of Incubation Time

Incubation time for the antigen–antibody interaction greatly influence the sensitivity of the developed immunosensor. The chronoamperometric technique was used to investigate the current responses of various immunochemical incubation times (from 5 to 40 min) of the immunosensor. The immunosensor was incubated in 30 ng/mL DONag MPBS solution (pH 7.2). It was observed that the current decreased as the incubation time increased and levelled off after 30 min, indicating the optimal formation of immune-complexes, therefore an incubation time of 30 min was adopted for subsequent analysis (see Figure 10).

3.6. Performance of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA Immunosensor

3.6.1. Calibration Curve

The immunosensor was incubated for 30 min in aliquots of a pH 7.2 methanolic phosphate buffer saline (MPBS) solution containing various concentrations of DONag. These different concentrations of DONag were tested and similar impedance spectra with increasing Rct as the concentration increased were obtained. Figure 11 shows the Nyquist diagrams of the immunosensor obtained after incubation in increasing concentrations (0, 6, 12, 18, 24 and 30 ng/mL) of DONag. The observed increase in Rct values with increasing DONag concentrations implies that more DONag are being bound to the interface and also indicates that the binding of DONag to the DONab immunosensor inhibits electron transfer at the sensing interface [21,25]. This reflected as an increase in charge transfer resistance in both imaginary and real impedance as shown in Figure 11.

The equivalent electrical circuit presented in the Figure 11a insert was used to fit the responses of the immunosensor to various standard DONag solutions in order to obtain the value of the charge transfer resistance at each concentration. Figure 11b shows expanded EIS spectra responses of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor to standard DONag solutions: a, b, c, d, e and f represents 0, 6, 12, 18, 24 and 30 ng/mL DON antigen respectively. In order to compare the different electrode measurements under the equivalent circuit conditions and obtain the normalised values that were plotted in Figure 12, the Rct value for the blank (0 ng/mL DONag) was subtracted from the Rct values of DONag concentrations. A linear relationship between the electron transfer resistance and DONag concentrations ranged from 0 to 30 ng/mL. When DONag was increased beyond 30 ng/mL, the change in impedance spectroscopy gradually levelled out indicating that all the available binding sites on the sensor were occupied by the DONag. The detection limit of 0.2994 μg/L was obtained on the basis of 3× S.D. of determination of the zero standards [26] and the sensitivity is 32.14286 ΩL/ng.

3.6.2. Stability, Reproducibility, Repeatability, and Selectivity of the Immunosensor

The stability of the GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor was assessed by impedimetrically measuring 30 ng/mL of DONag in MPBS solution at daily intervals for 5 days with the same sensor. Minimal detectable loss of the activity was observed in comparing the daily signals with the signal of freshly prepared immunosensor. The result shows that the immunosensor is 80.3% stable. The sensor was not measured after this period but longer term stability may be expected due to the strong covalent attachment of the antibody to the modified electrode which could prevent the antibody from leaking out from the surface.

The reproducibility of the immunosensor was investigated by measuring 30 ng/mL of DONag in MPBS solution using five similarly prepared immunosensors. Relative standard deviation of 6.5% was calculated. Such good precision reflects the reproducibility of the electrode modifications, immune-binding and impedimetric procedures. Its repeatability was investigated by five successive measurements of 30 ng/mL of DONag in MPBS solution using the same immunosensor. The relative standard deviation (RSD) for the five parallel impedimetric measurements is 6.9%. This result indicates that the repeatability of the sensor was within experimental error.

To investigate the selectivity of the immunosensor, it was incubated in 30 ng/mL DONab standard solution containing different interfering agents such as nudularin and fumonisin. No remarkable change of Rct was observed in comparison with that which contains only DONab except for the slight increase in Rct observed when fumonisn was added. The immunosensor was also incubated in 30 ng/mL fumonisin and 30 ng/mL nudularin standard solutions prepared in MPBS (pH7.2) solution. The same Rct value was obtained for 30 ng/mL nudularin standard solution compared to that of the blank MPBS (pH 7.2) solution while a slight increase in Rct value was observed for 30 ng/mL fumonisin (Figure 13). These results show that the immunosensor has good selectivity.

3.7. Detection of DONag Standards by Veratox ELISA Test Kit

Various standard concentrations of DONag were tested using ELISA method to valid the fabricated immunosensor. Veratox for DON 5/5 is a competitive direct enzyme-linked immunosorbent assay (CD-ELISA) which is intended for quantitative analysis of deoxynivalenol in grains and grain products, and it allows the user to detect DONag concentrations in parts per million (ppm). The concentration range of DONg standard for the Veratox ELISA was between 0.25–1.99 ppm. A standard calibration curve of absorbance versus DONag concentrations was plotted as shown in Figure 14. The sensitivity obtained from slope of the linear part of the graph was calculated to be 0.041 mg/L and the limit of detection was 2.1 ppm. These values represent a better feedback in detecting DONag and make the use of ELISA an appropriate technique in validating the fabricated immunosensor.

3.8. Real Sample Studies

The feasibility of the proposed impedimetric immunosensor for real sample analysis was investigated by detecting DONag in extracted certified reference materials of wheat; roasted coffee and corn following the extraction procedure described by Veratox Elisa Kit manual. The extracts from the reference materials were comparably analysed with GCE/Nafion/[Ru(bpy)3]2+/AuG/PhNH2/DONab and Veratox 5/5 ELISA kit and the results are shown in Table 1. The detected DONag values from the different extracts using the immunosensor were comparable to those obtained with Veratox ELISA as well as the quantity advertised by the vendor.

4. Conclusions

A gold nanoparticles-dotted 4-nitrophenylazo-functionalized graphene (AuNp/G/PhNO2) nanocatalyst was successfully used to fabricate a label-free electrochemical immunosensor for detection and determination of the mycotoxin deoxynivalenol in cereals. The impedimetric detection technique was employed and under the optimized conditions, the formation of immunocomplexes inhibited electron flow and increased the charge transfer resistance of the sensing interface linearly. The detection range of the immunosensor for deoxynivalenol (DONag) in standard samples was 6–30 ng/mL. Its sensitivity and detection limit were 32.14 ΩL/ng and 0.3 μg/L respectively, which were better than those reported in the literature and compare favorably with the ELISA result. The immunosensor is very simple to operate by direct immunoreaction detection without any label and competitive assay. The sensitivity of this sensor ensures its use, not only in the laboratory but also in the field. The immunosensor can be fabricated easily and it exhibits promising application prospects as a novel electrochemical sensor.

Acknowledgments

This study was funded by research grant from the South African National Research Foundation (NRF) and financial support of SensorLab University of the Western Cape South Africa.

Author Contributions

Christopher Edozie Sunday conducted the experiments and prepared the manuscript, Milua Masikini, Lindsay Wilson, Candice Rassie, Tesfaye Waryo contributed in discussing the manuscript, Pricilla G. L. Baker and Emmanuel I. Iwuoha supervised the work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sobrova, P.; Adam, V.; Vasatkova, A.; Beklova, M.; Zeman, L.; Kizek, R. Deoxynivalenol and Its Toxicity. Interdisc. Toxicol. 2010, 3, 94–99. [Google Scholar]
  2. Hajjaji, A.; El Otmani, M.; Bouya, D.; Bouseta, A.; Mathieu, F.; Collin, S.; Lebrihi, A. Occurrence of Mycotoxins: Ochratoxin a, Vomitoxin (Deoxynivalenol) and Toxigenic Fungi in Moroccan Wheat Grains: Impact of Ecological Factors on the Growth and Ochratoxin a Production. Mol. Nutr. Food Res. 2006, 10, 1–12. [Google Scholar]
  3. Christina, N.M.; Szilard, F.N.; Livia, B.; Joseph, M.; Bela, V. Hydrogen Bondings in Deoxynivalenol (Don) Conformations—A Density Functional Study. J. Mol. Struct. 2005, 3, 55–59. [Google Scholar]
  4. Gouze, M.E.; Laffitte, J.; Dedieu, G.; Galinier, A.; Thouvenot, J.P.; Oswald, I.P.; Galtier, P. Individual and Combined Effects of Low Oral Doses of Vomitoxin (Deoxynivalenol) (Don) and Nivalenol in Mice. Ferment. Biotechnol. 2005, 51, 13–18. [Google Scholar]
  5. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man; International Agency for Research on Cancer: Lyon CEDEX, France, 1993.
  6. Cetin, Y.; Bullerman, L.B. Confirmation of Reduced Toxicity of Vomitoxin (Deoxynivalenol) in Extrusion-Processed Corn Grits by the Mtt Bioassay. J. Agric. Food Chem. 2006, 5, 1949–1955. [Google Scholar]
  7. Stiles, P.L.; Dieringer, J.A.; Shah, N.C.; VanDuyne, R.P. Surface-Enhanced Raman Spectroscopy. Ann. Rev. Anal. Chem. 2008, 11, 601–626. [Google Scholar]
  8. Tritscher, A.M.; Samuel, P.W. The Risk Assessment Paradigm and Its Application for Trichothecenes. Toxicol. Lett. 2004, 1, 155–163. [Google Scholar]
  9. Amuzie, C.J. Biomarkers and Risk Assessment for Deoxynivalenol. Ph.D. Thesis, Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA, 2009. [Google Scholar]
  10. Maragos, C.M.; McCormick, S.P. Monoclonal Antibodies for the Mycotoxins Deoxynivalenol and 3-Acetyl-Deoxynivalenol. Food Agric. Immullol. 2000, 12, 181–192. [Google Scholar]
  11. Scarlett, B.; Lutz, H.; Heiner, W.; Hummert, C. Analysis of Fusarium Toxins Using LC-MS-MS: Application to Various Food and Feed Matrices. Spectroscopy 2005, 10, 1–8. [Google Scholar]
  12. Meneely, J.P.; Francesco, R.; Egmond, H.P.; Elliott, C.T. Current Methods of Analysis for the Determination of Trichothecene Mycotoxins in Food. Trends Anal. Chem. 2011, 2, 21–30. [Google Scholar]
  13. Wang, S.; Xiao-Yu, D.; Huang, Y.; De-Shu, L.; Patrick, L.H.; Wang, Z. Detection of Deoxynivalenol Based on a Single-Chainfragment Variable of the Antideoxynivalenol Antibody. FEMS Microbiol. Lett. 2007, 272, 214–219. [Google Scholar]
  14. Fang, J.; Hua, L.; Jianhong, X.; Jianrong, S. Enzyme-Linked Immunosorbent-Assay for Deoxynivalenol. Toxins 2011, 3, 968–978. [Google Scholar]
  15. Mahendra, K.R.; Bonde, S.R.; Ingle, A.P.; Gade, A.K. Mycotoxin: Rapid Detection, Differentiation and Safety. J. Pharm. Educ. Res. 2012, 1, 101–113. [Google Scholar]
  16. Molina, P.G.; Alicia, M.Z.; Fernandez, H. Novel Studies About the Electrooxidation of a Deoxynivalenol Mycotoxin Reduction Product Adsorbed on Glassy Carbon and Carbon Paste Electrodes. Electroanalysis 2008, 15, 1633–1638. [Google Scholar]
  17. Sunday, C.E.; Bilibana, M.; Qakala, S.; Tovide, O.; Molapo, K.M.; Fomo, G.; Ikpo, C.O.; Waryo, T.; Mbambisa, G.; Mpushe, B.; et al. Modulation of the Matrix Effect of Nafion on Tris(Bipyridine) Ruthenium(Ii) Electrochemical Probes by Functionalisation with 4-Nitrophenylazo Graphene-Gold Nanocomposite. Electrochim. Acta 2014, 128, 128–137. [Google Scholar]
  18. Brooksby, P.A.; Downard, A.J. Electrochemical and Atomic Force Microscopy Study of Carbon Surface Modification via Diazonium Reduction in Aqueous and Acetonitrile Solutions. Langmuir 2004, 20, 5038–5045. [Google Scholar]
  19. Allongue, P.; Delamar, M.; Desbat, B.; Fagebaume, O.; Hitmi, R.; Pinson, J.; Saveant, J.M. Covalent Modification of Carbon Surfaces by Aryl Radicals Generated from the Electrochemical Reduction of Diazonium Salts. J. Am. Chem. Soc. 1997, 119, 201–207. [Google Scholar]
  20. Radi, A.E.; Muñoz-Berbel, X.; Cortina-Puig, M.; Marty, J.L. An Electrochemical Immunosensor for Ochratoxin a Based on Immobilization of Antibodies on Diazonium-Functionalized Gold Electrode. Electrochim. Acta 2009, 10, 2180–2184. [Google Scholar]
  21. Wang, R.; Xue, C. A Sensitive Electrochemical Immunosensor for Alpha-Fetoprotein Based on Covalently Incorporating a Bio-Recognition Element onto a Graphene Modified Electrode via Diazonium Chemistry. Anal. Methods 2013, 12, 5195–5200. [Google Scholar]
  22. Liu, G.; Liu, J.; Davis, T.P.; Gooding, J.J. Electrochemical Impedance Immunosensor Based on Gold Nanoparticles and Aryl Diazonium Salt Functionalized Gold Electrodes for the Detection of Antibody. Biosens. Bioelectron. 2011, 26, 3660–3665. [Google Scholar]
  23. Aryl Diazonium Salts: New Coupling Agents in Polymer and Surface Science. In Attachment of Organic Layers to Materials Surfaces by Reduction of Diazonium Salts, 1st ed.; Chehimi, M.M., Ed.; Wiley-VCH Verlag GmbH & Co: Hoboken, NJ, USA, 2012.
  24. Chrouda, A.; Braiek, M.; Rokbani, K.B.; Bakhrouf, A.; Maaref, A.; Jaffrezic-Renault, N. An Immunosensor for Pathogenic Staphylococcus Aureus Based on Antibody Modified Aminophenyl-Au Electrode. ISRN Electrochem. 2013, 9. [Google Scholar] [CrossRef]
  25. La Belle, J.T.; Bhavsar, K.; Fairchild, A.; Das, A.; Sweeney, J.; Alford, T.L.; Wang, J.; Bhavanandan, V.P.; Joshi, L. A Cytokine Immunosensor for Multiple Sclerosis Detection Based Upon Label-Free Electrochemical Impedance Spectroscopy. Biosens. Bioelectron. 2007, 23, 428–431. [Google Scholar]
  26. Robinson, G.; Hill, H.; Philo, R.; Gear, J.M.; Rattle, S.J. Bioelectrochemical Enzyme Immunoassay of Human Choriogonadotropin with Magnetic Electrodes. Clin. Chem. 1985, 31, 1449–1452. [Google Scholar]
Figure 1. Chemical structure of the mycotoxin deoxynivalenol.
Figure 1. Chemical structure of the mycotoxin deoxynivalenol.
Sensors 15 03854f1 1024
Figure 2. The illustration for simultaneous chemical reduction of diazonium cation to diazonium radical, GO to graphene, in situ PhNO2 functionalisation of graphene and the immobilization of gold nanoparticles onto nitrophenylazo functionalized graphene surface.
Figure 2. The illustration for simultaneous chemical reduction of diazonium cation to diazonium radical, GO to graphene, in situ PhNO2 functionalisation of graphene and the immobilization of gold nanoparticles onto nitrophenylazo functionalized graphene surface.
Sensors 15 03854f2 1024
Figure 3. Schematic representation for stepwise fabrication of the label-free impedimetric deoxynivalenol immunosensor.
Figure 3. Schematic representation for stepwise fabrication of the label-free impedimetric deoxynivalenol immunosensor.
Sensors 15 03854f3 1024
Figure 4. Electrochemical reduction of 4-nitrophenyl group to 4-aminophenyl on the electrode surface.
Figure 4. Electrochemical reduction of 4-nitrophenyl group to 4-aminophenyl on the electrode surface.
Sensors 15 03854f4 1024
Figure 5. CV of (i) bare GCE, (ii) GCE/Nafion/[Ru(bpy)3]2+/G/PhNO2 and (iii) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 recorded in 5 mM [Ru(NH3)6]2+/3+.
Figure 5. CV of (i) bare GCE, (ii) GCE/Nafion/[Ru(bpy)3]2+/G/PhNO2 and (iii) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2 recorded in 5 mM [Ru(NH3)6]2+/3+.
Sensors 15 03854f5 1024
Figure 6. CV response of different immobilisation steps: (i) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2, (ii) after immobilization of DON antibody, (iii) after blocking nonspecific binding sites with BSA and (iv) after immobilization and running in standard DON solutions at scan rate of 50 mV/s, over potential range of 650–1350 mV.
Figure 6. CV response of different immobilisation steps: (i) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2, (ii) after immobilization of DON antibody, (iii) after blocking nonspecific binding sites with BSA and (iv) after immobilization and running in standard DON solutions at scan rate of 50 mV/s, over potential range of 650–1350 mV.
Sensors 15 03854f6 1024
Figure 7. (a) Chronoamperometric responses, and (b) bar chart for the chronoamperograms of different immobilisation steps: (i) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2, (ii) after immobilization of DON antibody, (iii) after blocking nonspecific binding sites with BSA and (iv) after immobilization and running in standard DON solutions.
Figure 7. (a) Chronoamperometric responses, and (b) bar chart for the chronoamperograms of different immobilisation steps: (i) GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2, (ii) after immobilization of DON antibody, (iii) after blocking nonspecific binding sites with BSA and (iv) after immobilization and running in standard DON solutions.
Sensors 15 03854f7a 1024Sensors 15 03854f7b 1024
Figure 8. The plot of Rct values versus deoxynivalenol antibody concentrations.
Figure 8. The plot of Rct values versus deoxynivalenol antibody concentrations.
Sensors 15 03854f8 1024
Figure 9. The plot of anodic peak currents from CV versus solution pH.
Figure 9. The plot of anodic peak currents from CV versus solution pH.
Sensors 15 03854f9 1024
Figure 10. The plot of peak currents from chronoamperograms versus incubation time.
Figure 10. The plot of peak currents from chronoamperograms versus incubation time.
Sensors 15 03854f10 1024
Figure 11. (a). EIS responses of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor to standard DONag solutions: a, b, c, d, e and f represents 0, 6, 12, 18, 24 and 30 ng/mL DON antigen respectively; (b). Expanded EIS spectra responses of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor to standard DONag solutions indicating the characteristic Rct semi-circle over the high frequency range and a straight line over the low frequency range.
Figure 11. (a). EIS responses of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor to standard DONag solutions: a, b, c, d, e and f represents 0, 6, 12, 18, 24 and 30 ng/mL DON antigen respectively; (b). Expanded EIS spectra responses of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab/BSA immunosensor to standard DONag solutions indicating the characteristic Rct semi-circle over the high frequency range and a straight line over the low frequency range.
Sensors 15 03854f11 1024
Figure 12. The calibration plot of EIS detection data of the immunosensor.
Figure 12. The calibration plot of EIS detection data of the immunosensor.
Sensors 15 03854f12 1024
Figure 13. The selectivity chart of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab immunosensor.
Figure 13. The selectivity chart of GCE/Nafion/[Ru(bpy)3]2+/AuNp/G/PhNH2/DONab immunosensor.
Sensors 15 03854f13 1024
Figure 14. The detection plot of DONag standards by ELISA.
Figure 14. The detection plot of DONag standards by ELISA.
Sensors 15 03854f14 1024
Table 1. DON content of corn, wheat and roasted coffee certified reference materials
Table 1. DON content of corn, wheat and roasted coffee certified reference materials
Certified Reference MaterialsDON Immunosensor (ppm)ELISA (ppm)Vendor (ppm)
Wheat0.30.20.71
Corn0.921.11.88
Roasted coffee0.190.240.77

Share and Cite

MDPI and ACS Style

Sunday, C.E.; Masikini, M.; Wilson, L.; Rassie, C.; Waryo, T.; Baker, P.G.L.; Iwuoha, E.I. Application on Gold Nanoparticles-Dotted 4-Nitrophenylazo Graphene in a Label-Free Impedimetric Deoxynivalenol Immunosensor. Sensors 2015, 15, 3854-3871. https://doi.org/10.3390/s150203854

AMA Style

Sunday CE, Masikini M, Wilson L, Rassie C, Waryo T, Baker PGL, Iwuoha EI. Application on Gold Nanoparticles-Dotted 4-Nitrophenylazo Graphene in a Label-Free Impedimetric Deoxynivalenol Immunosensor. Sensors. 2015; 15(2):3854-3871. https://doi.org/10.3390/s150203854

Chicago/Turabian Style

Sunday, Christopher Edozie, Milua Masikini, Lindsay Wilson, Candice Rassie, Tesfaye Waryo, Pricilla G. L. Baker, and Emmanuel I. Iwuoha. 2015. "Application on Gold Nanoparticles-Dotted 4-Nitrophenylazo Graphene in a Label-Free Impedimetric Deoxynivalenol Immunosensor" Sensors 15, no. 2: 3854-3871. https://doi.org/10.3390/s150203854

Article Metrics

Back to TopTop